| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis and Lipoproteins |
From the Department of Cell Biology (H.F.H., J.O., Z.W., G.H.), Lerner Research Institute, Cleveland Clinic Foundation, and the Department of Chemistry (R.L.S.), Case Western Reserve University, Cleveland, Ohio.
Correspondence to Henry F. Hoff, PhD, Department of Cell Biology, Lerner Research Institute, NC-10, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail hoffh{at}ccf.org
Objective Phosphatidylcholine hydroxyalkenals (PC-HAs) are a class of oxidized PCs derived from lipid peroxidation of arachidonate or linoleate at the sn-2 position to form terminal
-hydroxy,
-, and ß-unsaturated aldehydes. The aim of this study was to characterize some of their biological properties, ascertain the mechanism of their action, and assess whether they have in vivo relevance.
Methods and Results Combinations of cell biological approaches with radiolabels, mass spectroscopy, and immunochemical as well as immunohistochemical techniques were used to show that PC-HAs reduce the proteolytic degradation by mouse peritoneal macrophages (MPMs) of internalized macromolecules, such as maleylated bovine serum albumin, and that the activity of the lysosomal protease, cathepsin B, in MPMs form Michael adducts with MPM proteins and with N-acetylated cysteine in vitro form pyrrole adducts with MPM proteins and reduce the maturation of Rab5a, thereby impairing phagosome-lysosome fusion (maturation) in phagocytes; they are present unbound and as pyrrole adducts in human atherosclerotic lesions.
Conclusions PC-HAs are present in vivo and possess multiple functions characteristic of oxidized LDL and 4-hydroxynonenal.
Key Words: oxidized phospholipids macrophages intracellular degradation biochemical adducts atherosclerotic lesions Rab5
This article has been cited by other articles:
![]() |
O. V. Oskolkova, T. Afonyushkin, A. Leitner, E. von Schlieffen, P. S. Gargalovic, A. J. Lusis, B. R. Binder, and V. N. Bochkov ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response Blood, July 15, 2008; 112(2): 330 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Ashraf, N. S. Kar, X. Chen, J. Choi, R. G. Salomon, M. Febbraio, and E. A. Podrez Specific Oxidized Phospholipids Inhibit Scavenger Receptor BI-mediated Selective Uptake of Cholesteryl Esters J. Biol. Chem., April 18, 2008; 283(16): 10408 - 10414. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, W. Zhang, J. Laird, S. L. Hazen, and R. G. Salomon Polyunsaturated phospholipids promote the oxidation and fragmentation of {gamma}-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids J. Lipid Res., April 1, 2008; 49(4): 832 - 846. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Davis, G. Koster, L. J. Douet, M. Scigelova, G. Woffendin, J. M. Ward, A. Smith, J. Humphries, K. G. Burnand, C. H. Macphee, et al. Electrospray Ionization Mass Spectrometry Identifies Substrates and Products of Lipoprotein-associated Phospholipase A2 in Oxidized Human Low Density Lipoprotein J. Biol. Chem., March 7, 2008; 283(10): 6428 - 6437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. SALOMON Isolevuglandins, Oxidatively Truncated Phospholipids, and Atherosclerosis Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 327 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sowell, B. Frei, and J. F. Stevens Vitamin C conjugates of genotoxic lipid peroxidation products: Structural characterization and detection in human plasma PNAS, December 28, 2004; 101(52): 17964 - 17969. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Srivastava, M. Spite, J. O. Trent, M. B. West, Y. Ahmed, and A. Bhatnagar Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids J. Biol. Chem., December 17, 2004; 279(51): 53395 - 53406. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |